PACTR201409000782309已完成未知
Randomized open-label trial to evaluate the efficacy of artesunate-amodiaquin for seasonal malaria chemoprevention in suburban school of Bamako, Sirakoro-Meguetana, Mali
Malaria Research and Training Center/Faculty of Medecine and Dentistry/University of Sceinces, Techniques and Technologies0 个研究点目标入组 200 人开始时间: 2014年3月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Year(s) 至 15 Year(s)（—）
- 性别
- All
入选标准
- •Children aged 6-15 years;
- •- Enrolled in basic school Sirakoro Meguètana;
- •- Available and able to follow-up study visits;
- •- Do not show any general danger signs (inability to drink, uncontrollable vomiting, history of convulsion, lethargy, inability to sit unaided) or other signs of severe and complicated malaria falciparum according to the criteria of WHO;
- •- Obtaining informed consent from child parents or guardian;
- •- No history of hypersensitivity reactions to study drugs reported ;
排除标准
- •- Presence of biological abnormalities identified at enrollment
- •- Presence of any acute illness
- •- Presence of chronic diseases (diabetes, High blood pressure etc.).
- •- Presence of an evident pregnancy or revealed by a biological test
- •- History of antimalarial treatment (ACTs or other) within 15 days before enrollment
研究者
相似试验
进行中（未招募）
1 期
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancerCTIS2023-508219-21-00Jazz Pharmaceuticals Ireland Limited243
尚未招募
3 期
An open-label randomized trial of zanidatamab for advanced HER2-positive biliary tract cancerCTRI/2024/08/072371Jazz Pharmaceuticals Ireland Limited
进行中（未招募）
4 期
A trial to assess the efficacy of a new drug versus standard care for anaemia following colorectal cancer surgeryAnaemia with colorectal cancerCancerISRCTN12290106The Royal Wolverhampton NHS Trust42
招募中
4 期
Efficacy and safety evaluation of Suprotac® in comparison with Prograf® in prevention of liver transplant rejectioiver transplant.Liver transplant statusZ94.4IRCT20150303021315N25anoalvand Company196
已完成
不适用
A randomised open label trial to assess the efficacy, safety, and pharmacokinetic parameters of a fixed dose formulation of artesunate-mefloquine and standard dose artesunate and mefloquine as loose tablets for treatment of uncomplicated falciparum malaria (Thailand)Infections and InfestationsMalariaISRCTN24192353Drugs for Neglected Diseases initiative (DNDi) (Switzerland)50